Traphaco JSC (TRA) - Total Liabilities

Latest as of March 2026: ₫837.63 Billion VND ≈ $31.83 Million USD

Based on the latest financial reports, Traphaco JSC (TRA) has total liabilities worth ₫837.63 Billion VND (≈ $31.83 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Traphaco JSC growing its equity to track the company's year-over-year net asset growth rate.

Traphaco JSC - Total Liabilities Trend (2019–2025)

This chart illustrates how Traphaco JSC's total liabilities have evolved over time, based on quarterly financial data. See TRA FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Traphaco JSC Competitors by Total Liabilities

The table below lists competitors of Traphaco JSC ranked by their total liabilities.

Company Country Total Liabilities
Shinwon
KO:009270
Korea ₩462.41 Billion
Delta Technologies Nyrt
BUD:DELTA
Hungary Ft10.84 Billion
KAISA GROUP HLDGS
F:KG5
Germany €164.70 Billion
Agripure Holdings Public Company Limited
BK:APURE
Thailand ฿512.45 Million
Ta Chia Yung Ho Machine Industry Co Ltd
TWO:2221
Taiwan NT$510.78 Million
ImageneBio, Inc.
NASDAQ:IMA
USA $13.36 Million
Brimstone Investment Corporation Limited
JSE:BRN
South Africa ZAC1.39 Billion
Austco Healthcare Ltd
AU:AHC
Australia AU$39.34 Million

Liability Composition Analysis (2019–2025)

This chart breaks down Traphaco JSC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Traphaco JSC.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.20 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.58 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.35 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Traphaco JSC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Traphaco JSC (2019–2025)

The table below shows the annual total liabilities of Traphaco JSC from 2019 to 2025.

Year Total Liabilities Change
2025-12-31 ₫636.32 Billion
≈ $24.18 Million
+0.02%
2024-12-31 ₫636.21 Billion
≈ $24.17 Million
+0.22%
2023-12-31 ₫634.85 Billion
≈ $24.12 Million
+45.71%
2022-12-31 ₫435.71 Billion
≈ $16.55 Million
-0.88%
2021-12-31 ₫439.57 Billion
≈ $16.70 Million
-8.11%
2020-12-31 ₫478.38 Billion
≈ $18.18 Million
+5.49%
2019-12-31 ₫453.48 Billion
≈ $17.23 Million
--

About Traphaco JSC

VN:TRA Vietnam Drug Manufacturers - Specialty & Generic
Market Cap
$59.69 Million
₫1.57 Trillion VND
Market Cap Rank
#21241 Global
#156 in Vietnam
Share Price
₫37900.00
Change (1 day)
+0.00%
52-Week Range
₫37200.00 - ₫81700.00
All Time High
₫103027.02
About

Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. The company offers medical supplies; antipyretics; medicines for the hair, eyes, central neutral system, respiratory system, and liver; and other products. It is also involved in the production of medicines to treat human diseases,… Read more